Novacyt Announces Unaudited Consolidated Revenues Results for the Six Months Ended June 30, 2017; Provides Revenues Guidance for 2017
The company is targeting continued sales growth in second half of 2017 through: NOVAprep® Product registrations throughout 19 countries in South America and further investment in Asia Pacific; Primerdesign Conversion of business-to-business opportunities; and Lab21 The launch of new products into multiple territories, including Brazil and America and recovery of key tenders.